Seth Blackley - Evolent Health CEO CoFounder

9EH Stock  EUR 10.70  0.40  3.88%   

CEO

Mr. Seth Blackley is President, CoFounder, Director of the Company, Prior to cofounding the Company, Mr. Blackley was the Executive Director of Corporationrationrate Development and Strategic Planning at The Advisory Board from June 2007 to August 2011. From 2014 to 2016, Mr. Blackley served on the board of directors of Advanced Practice Strategies. Mr. Blackley is currently a board member of Access Clinical Partners and Iodine Healthcare. Mr. Blackley began his career as an analyst in the Washington, D.C. office of McKinsey Company since 2018.
Age 44
Tenure 6 years
Professional MarksMBA
Phone571 389 6000
Webhttps://www.evolenthealth.com
Blackley holds a bachelor of arts degree in business from The University of North Carolina at Chapel Hill, and a master of business administration from Harvard Business School. We believe that Mr. Blackley is qualified to serve on our Board because of his extensive experience in finance, strategy and operations, especially in the field of healthcare, and his extensive knowledge in all aspects of our business.

Seth Blackley Latest Insider Activity

Tracking and analyzing the buying and selling activities of Seth Blackley against Evolent Health stock is an integral part of due diligence when investing in Evolent Health. Seth Blackley insider activity provides valuable insight into whether Evolent Health is net buyers or sellers over its current business cycle. Note, Evolent Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Evolent Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Evolent Health Management Efficiency

Evolent Health's management efficiency ratios could be used to measure how well Evolent Health manages its routine affairs as well as how well it operates its assets and liabilities.
Evolent Health has accumulated 215.68 M in total debt with debt to equity ratio (D/E) of 24.6, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Evolent Health has a current ratio of 1.92, which is within standard range for the sector. Debt can assist Evolent Health until it has trouble settling it off, either with new capital or with free cash flow. So, Evolent Health's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Evolent Health sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Evolent to invest in growth at high rates of return. When we think about Evolent Health's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 4 records

CEO Age

Serge Saxonov10X GENOMICS DL
42
Jason GorevicTeladoc
51
Peter GassnerVeeva Systems
58
Jon KesslerHealthequity
55
Evolent Health, Inc., through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia. EVOLENT HEALTH operates under Health Information Services classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3800 people. Evolent Health (9EH) is traded on Frankfurt Exchange in Germany and employs 4,000 people.

Management Performance

Evolent Health Leadership Team

Elected by the shareholders, the Evolent Health's board of directors comprises two types of representatives: Evolent Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Evolent. The board's role is to monitor Evolent Health's management team and ensure that shareholders' interests are well served. Evolent Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Evolent Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jonathan JD, Gen Officer
Aammaad Shams, Chief Controller
Jessica Somers, Sr Devel
Seth Frank, VP Relations
MAAA FSA, Chief Officer
John Johnson, Chief Officer
Seth Blackley, CEO CoFounder
Frank Williams, CoFounder Chairman
Kali Beyah, Chief Officer
Dan McCarthy, CEO Pres

Evolent Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Evolent Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Evolent Stock

When determining whether Evolent Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Evolent Health's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Evolent Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Evolent Health Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Evolent Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more detail on how to invest in Evolent Stock please use our How to Invest in Evolent Health guide.
You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Please note, there is a significant difference between Evolent Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evolent Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evolent Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.